NEW YORK, Feb. 23 (GenomeWeb News) - Acacia Research group CombiMatrix will collaborate with researchers at Case Western Reserve University to develop a diagnostic test for Alzheimer's disease, the company said today.
The university scientists, led by Mark Smith at the Department of Pathology, will use CombiMatrix's CustomArray microarray platform in their research.
CombiMatrix's platform uses electrochemically and independently addressable microelectrodes on semiconductor chips.